文献速递脊髓损伤康复心肺康复

脊髓损伤合并糖代谢异常者的肠道菌群与血清代谢组特征

Gut Microbiome Composition and Serum Metabolome Profile Among Individuals With Spinal Cord Injury and Normal Glucose Tolerance or Prediabetes/Type 2 Diabetes.
PubMed 文献 · Arch Phys Med Rehabil · 2021-06-12

该横断面研究纳入25例脊髓损伤成人,按75g口服葡萄糖耐量试验120分钟血糖分为正常糖耐量组(n=16)与糖尿病前期/2型糖尿病组(n=9),比较粪便16S rRNA测序的肠道菌群组成与空腹血清LC-MS非靶向代谢组。结果显示两组菌群α多样性与β多样性存在差异,糖尿病前期/2型糖尿病组梭菌目丰度更低、阿克曼菌属丰度更高,血清吲哚硫酸盐与苯乙酰谷氨酰胺水平更高(P<.05)。

要点

  • 脊髓损伤合并糖尿病前期/2型糖尿病者肠道菌群均匀度降低,梭菌目减少、阿克曼菌属增多。
  • 该类患者血清肠源性代谢物吲哚硫酸盐与苯乙酰谷氨酰胺水平升高。
  • 上述代谢物在健全人群中与心血管疾病相关,提示需关注脊髓损伤患者心代谢健康。

核心结论

  • 脊髓损伤合并糖尿病前期/2型糖尿病者存在肠道菌群组成改变及肠源性代谢物失调。

研究设计与样本

  • 横断面设计,纳入25例脊髓损伤成人,按75g口服葡萄糖耐量试验120分钟血糖及美国糖尿病协会诊断指南分为正常糖耐量组16例与糖尿病前期/2型糖尿病组9例。

主要发现

  • 两组肠道菌群α多样性(Pielou均匀度指数、Shannon指数)与β多样性(加权UniFrac距离)存在差异。
  • 与正常糖耐量组相比,糖尿病前期/2型糖尿病组菌群均匀度更低。
  • 糖尿病前期/2型糖尿病组梭菌目丰度更低、阿克曼菌属丰度更高。
  • 糖尿病前期/2型糖尿病组血清吲哚硫酸盐与苯乙酰谷氨酰胺水平更高(P<.05)。

关键数值与推荐

  • 分组依据为75g口服葡萄糖耐量试验120分钟血糖,采用美国糖尿病协会诊断指南。
  • 菌群分析采用16S核糖体RNA测序,代谢组分析采用液相色谱-质谱非靶向代谢组学。
  • 菌群与代谢组数据分别经QIIME 2与MetaboAnalyst平台分析。

临床怎么用

  • 对脊髓损伤患者评估糖代谢时,可关注肠道菌群与肠源性代谢物对心代谢风险的潜在影响。
  • 吲哚硫酸盐与苯乙酰谷氨酰胺可作为未来脊髓损伤心代谢健康研究的候选标志物。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To compare the gut microbiome composition and serum metabolome profile among individuals with spinal cord injury (SCI) and normal glucose tolerance (NGT) or prediabetes/type 2 diabetes (preDM/T2D). DESIGN: Cross-sectional design. SETTING: Research university. PARTICIPANTS: A total of 25 adults (N=25) with SCI were included in the analysis and categorized as NGT (n=16) or preDM/T2D (n=9) based on their glucose concentration at minute 120 during a 75-g oral glucose tolerance test. The American Diabetes Association diagnosis guideline was used for grouping participants. INTERVENTIONS: Not applicable. MAIN OUTCOME MEASURES: A stool sample was collected and used to assess the gut microbiome composition (alpha and beta diversity, microbial abundance) via the 16s ribosomal RNA sequencing technique. A fasting serum sample was used for liquid chromatography-mass spectrometry-based untargeted metabolomics analysis, the results from which reflect the relative quantity of metabolites detected and identified. Gut microbiome and metabolomics data were analyzed by the Quantitative Insights into Microbial Ecology 2 and Metaboanalyst platforms, respectively. RESULTS: Gut microbiome alpha diversity (Pielou's evenness index, Shannon's index) and beta diversity (weighted UniFrac distances) differed between groups. Compared with participants with NGT, participants with preDM/T2D had less evenness in microbial communities. In particular, those with preDM/T2D had a lower abundance of the Clostridiales order and higher abundance of the Akkermansia genus, as well as higher serum levels of gut-derived metabolites, including indoxyl sulfate and phenylacetylglutamine (P < .05 for all). CONCLUSIONS: Our results provide evidence for altered gut microbiome composition and dysregulation of gut-derived metabolites in participants with SCI and preDM/T2D. Both indoxyl sulfate and phenylacetylglutamine have been implicated in the development of cardiovascular diseases in the able-bodied population. These findings may inform future investigations in the field of SCI and cardiometabolic health.

来源:Arch Phys Med Rehabil,查看原文。版权归原作者所有。

引用

  1. Li J, Morrow C, Barnes S, et al. Gut Microbiome Composition and Serum Metabolome Profile Among Individuals With Spinal Cord Injury and Normal Glucose Tolerance or Prediabetes/Type 2 Diabetes. Arch Phys Med Rehabil. 2021. PMID: 34126067. doi:10.1016/j.apmr.2021.03.043

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。